DE2760097C2 - - Google Patents

Info

Publication number
DE2760097C2
DE2760097C2 DE2760097A DE2760097A DE2760097C2 DE 2760097 C2 DE2760097 C2 DE 2760097C2 DE 2760097 A DE2760097 A DE 2760097A DE 2760097 A DE2760097 A DE 2760097A DE 2760097 C2 DE2760097 C2 DE 2760097C2
Authority
DE
Germany
Prior art keywords
methyl
furanyl
ethyl
thio
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2760097A
Other languages
German (de)
English (en)
Inventor
Barry John Price
John Watson Clitherow
John Bradshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE2760097(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Application granted granted Critical
Publication of DE2760097C2 publication Critical patent/DE2760097C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE2760097A 1976-08-04 1977-07-28 Expired DE2760097C2 (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (1)

Publication Number Publication Date
DE2760097C2 true DE2760097C2 (xx) 1989-08-17

Family

ID=27448487

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2759959A Expired DE2759959C2 (xx) 1976-08-04 1977-07-28
DE2760097A Expired DE2760097C2 (xx) 1976-08-04 1977-07-28

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2759959A Expired DE2759959C2 (xx) 1976-08-04 1977-07-28

Country Status (16)

Country Link
AT (1) AT375931B (xx)
CH (2) CH642072A5 (xx)
CY (1) CY1077A (xx)
DE (2) DE2759959C2 (xx)
DK (2) DK148258C (xx)
ES (2) ES461334A1 (xx)
FI (1) FI72318C (xx)
HK (1) HK55780A (xx)
IE (1) IE45456B1 (xx)
IT (2) IT1126759B (xx)
KE (1) KE3080A (xx)
NZ (2) NZ191383A (xx)
PH (1) PH13540A (xx)
PT (1) PT66874B (xx)
SE (3) SE437373B (xx)
YU (2) YU40006B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (sh) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj POSTUPAK ZA sintezu N-[2[[[5=[(DIALKILAMINO)METIL]-2= FURANIL]METIL]TIO]ETIL]-N'-ALKIL-2-NITRO 1,1 ALKENDIAMINA I NJIHOVIH HIDROHLORIDA

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Also Published As

Publication number Publication date
HK55780A (en) 1980-10-10
DK337977A (da) 1978-02-05
SE8206556L (sv) 1982-11-17
CH642072A5 (en) 1984-03-30
CY1077A (en) 1980-12-27
IT1126759B (it) 1986-05-21
DK149952C (da) 1987-07-06
DE2759959C2 (xx) 1988-08-04
KE3080A (en) 1980-10-03
DK416384D0 (da) 1984-08-30
IT1221058B (it) 1990-06-21
SE7708521L (sv) 1978-02-05
SE454882B (sv) 1988-06-06
SE8205533L (sv) 1982-09-28
SE437373B (sv) 1985-02-25
IE45456B1 (en) 1982-08-25
IT8548437A0 (it) 1985-08-01
YU40088B (en) 1985-06-30
SE8205533D0 (sv) 1982-09-28
SE454883B (sv) 1988-06-06
PH13540A (en) 1980-06-26
FI772264A (xx) 1978-02-05
DK148258B (da) 1985-05-20
AT375931B (de) 1984-09-25
FI72318B (fi) 1987-01-30
FI72318C (fi) 1987-05-11
PT66874B (en) 1979-01-23
ES461334A1 (es) 1979-05-16
YU200082A (en) 1983-01-21
NZ191383A (en) 1980-09-12
DK416384A (da) 1984-08-30
IE45456L (en) 1978-02-04
ES470836A1 (es) 1979-02-16
SE8206556D0 (sv) 1982-11-17
YU191177A (en) 1983-01-21
DK149952B (da) 1986-11-03
YU40006B (en) 1985-06-30
ATA574077A (de) 1984-02-15
PT66874A (en) 1977-09-01
DK148258C (da) 1985-10-14
CH641176A5 (en) 1984-02-15
NZ184759A (en) 1980-09-12

Similar Documents

Publication Publication Date Title
DE2734070A1 (de) Aminoalkylfuranderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2951675C2 (de) Guanidinothiazolverbindungen, Verfahren zu deren Herstellung und Arzneimittelzubereitungen
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2821409A1 (de) Aminoalkylthiophenverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3047142C2 (de) Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
DE2836073A1 (de) Neue nitroimidazole und verfahren zu deren herstellung
CH643238A5 (en) Aminoalkylbenzene derivatives having a selective action on histamine receptors
DE2922523A1 (de) Neue aminothiazole und diese enthaltende arzneimittel
DD149217A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DE3232462A1 (de) 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE4341402A1 (de) N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE2946332A1 (de) Alpha , omega -disubstituierte polymethylenverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2760097C2 (xx)
DE2658558A1 (de) Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4169855A (en) N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine
AT390952B (de) Verfahren zur herstellung von neuen furan- oder thiophenderivaten
DD209628A5 (de) Verfahren zur herstellung von imidazolinderivaten
DD202019A5 (de) Verfahren zur herstellung von 3,4-disubstituierten 1,2,5-oxadiazol-2-oxiden
CH645615A5 (de) 1,1,3,5-substituierte biuretverbindung und pharmazeutische mittel.
DE2655232A1 (de) Aethanolaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
CH651560A5 (en) Aminoalkylfuran derivatives, and drugs containing these compounds
CH640846A5 (en) Aminoalkylfuran derivative
AT381937B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten sowie deren tautomeren, diastereoisomeren bzw. optischen enantiomeren
DE2342312A1 (de) Substituierte 2-hydroxyguanidino-carbamate
DE2720968C2 (de) N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2734070

AC Divided out of

Ref country code: DE

Ref document number: 2734070

Format of ref document f/p: P

8141 Disposal/no request for examination
8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 2734070

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee